Conversely, aside from BRCA2, no reduction in survival time for PrCa cases dying from other non-PrCa causes was observed between carriers and noncarriers, although this analysis was limited by a lower number of events. The gene discussed is BRCA2; the disease is pure red-cell aplasia.